Big Pharma Fails 50% of the Time in Phase Three. AI Can Fix That | Vin Singh, BullFrog AI
It costs up to $2 billion and fifteen years to develop a drug, and big pharma still fails half the time at the final stage. BullFrog AI founder, Chairman, and CEO Vin Singh joins Craig Smith with a clear diagnosis of why: the industry keeps picking the wrong drug target from the beginning, and no amount of downstream…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Eye On A.I.
See all episodes →
57%Inside Ukraine's Azov Drone R&D: The Engineer Building AI Weapons 18 km From the Front Line | Alexander Palamarchuk
56%Inside Ukraine's Drone War: Maj. "Phoenix" of Lasar's Group
55%From 10 Drones a Month to Nearly 100,000 — Inside Ukraine's Largest Drone Manufacturer | Marko Kushnir, General Cherry
Similar episodes from other shows
More like Eye On A.I. →
EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
🔬 Training Transformers to solve 95% failure rate of Cancer Trials — Ron Alfa & Daniel Bear, Noetik
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
Andreessen Horowitz's Vijay Pande: "AI doctors"
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.